APLM Stock Posts

APLM Apollomics - Class A18.430.000.0%

Premarket:17.00-1.43 (-7.8%)

Nasdaq Resumes Trading in Apollomics Inc.

Globe NewswireTue, 14-Oct 4:05 PM

APLM Apollomics - Class A9.37+1.48+18.8%

Premarket:8.19-1.18 (-12.6%)

Apollomics Announces Top-line Results for Phase 3 Bridging Trial of Uproleselan in China in Patients with Relapsed or Refractory Acute Myeloid Leukemia

Globe NewswireFri, 20-Dec 8:00 AM

APLM Apollomics - Class A29.400.000.0%

Premarket:29.00-0.40 (-1.4%)

Qiming Venture Partners Welcomes Apollomics' Successful IPO on Nasdaq

PRNewswireFri, 31-Mar 7:34 AM